Clarke G A, Letchworth A T, Noble A D
J Perinat Med. 1980;8(5):236-40. doi: 10.1515/jpme.1980.8.5.236.
Two hundred and sixty-one patients of varying parity and cervical "ripeness" were given Prostaglandin E2 (PCE2) in tylose gel either vaginally (2.0 mgm) or extraamniotically (0.3 mgm) prior to planned surgical induction. Surgical inductions was avoided in 52 per cent of the vaginal group and 40 per cent of the extra-amniotic group. When subdivided according to parity and cervical ripeness, both groups were comparable except in the multigravid patients with high cervical 'scores', when the vaginal route was significantly more likely to establish labor. Both groups were without significant ill-effects to the mother or fetus.
261名不同孕次和宫颈“成熟度”的患者在计划手术引产之前,经阴道给予含0.2毫克米索前列醇的前列腺素E2(PCE2)凝胶(2.0毫克)或羊膜外给予(0.3毫克)。阴道给药组52%和羊膜外给药组40%避免了手术引产。根据孕次和宫颈成熟度细分时,除了多产妇宫颈“评分”高的情况外,两组具有可比性,此时经阴道途径更有可能启动分娩。两组对母亲或胎儿均无明显不良影响。